DK1497289T3 - Drug containing betamimetics and a new anticholinergic - Google Patents

Drug containing betamimetics and a new anticholinergic

Info

Publication number
DK1497289T3
DK1497289T3 DK03746158T DK03746158T DK1497289T3 DK 1497289 T3 DK1497289 T3 DK 1497289T3 DK 03746158 T DK03746158 T DK 03746158T DK 03746158 T DK03746158 T DK 03746158T DK 1497289 T3 DK1497289 T3 DK 1497289T3
Authority
DK
Denmark
Prior art keywords
drug containing
betamimetics
new anticholinergic
anticholinergic
containing betamimetics
Prior art date
Application number
DK03746158T
Other languages
Danish (da)
Inventor
Rolf Banholzer
Christopher John Montagu Meade
Helmut Meissner
Gerd Morschhaeuser
Michel Pairet
Michael P Pieper
Gerald Pohl
Richard Reichl
Georg Speck
Ingo Konetzki
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10256317A external-priority patent/DE10256317A1/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1497289T3 publication Critical patent/DK1497289T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention relates to novel medicament compositions based on long-acting beta2 agonists and salts of a novel anticholinesterase drug (I), to methods for the production of these compositions and their use in treating respiratory tract diseases.
DK03746158T 2002-04-12 2003-04-09 Drug containing betamimetics and a new anticholinergic DK1497289T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10216428 2002-04-12
DE10256317A DE10256317A1 (en) 2002-04-12 2002-12-03 Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt
PCT/EP2003/003669 WO2003087097A1 (en) 2002-04-12 2003-04-09 Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Publications (1)

Publication Number Publication Date
DK1497289T3 true DK1497289T3 (en) 2005-10-24

Family

ID=29251756

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03746158T DK1497289T3 (en) 2002-04-12 2003-04-09 Drug containing betamimetics and a new anticholinergic

Country Status (19)

Country Link
EP (1) EP1497289B1 (en)
JP (1) JP2005529111A (en)
CN (1) CN1646527A (en)
AT (1) ATE302774T1 (en)
AU (1) AU2003232201B2 (en)
BR (1) BR0309185A (en)
CA (1) CA2481468C (en)
DK (1) DK1497289T3 (en)
ES (1) ES2248767T3 (en)
HR (1) HRP20040944B1 (en)
IL (1) IL164291A (en)
MX (1) MXPA04009916A (en)
NO (1) NO20044107L (en)
NZ (1) NZ536337A (en)
PL (1) PL213489B1 (en)
PT (1) PT1497289E (en)
RS (1) RS50735B (en)
UY (1) UY27757A1 (en)
WO (1) WO2003087097A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040950A1 (en) 2003-02-14 2005-01-01 Theravance Inc BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS
US7244728B2 (en) 2004-03-17 2007-07-17 Boehringer Ingelheim International Gmbh Long acting betamimetics for the treatment of respiratory diseases
EP1577306A1 (en) * 2004-03-17 2005-09-21 Boehringer Ingelheim Pharma GmbH & Co.KG novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
AU2006218177B2 (en) 2005-02-25 2012-04-12 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
JP2009504624A (en) 2005-08-08 2009-02-05 アージェンタ ディスカバリー リミテッド Bicyclo [2.2.1] hept-7-ylamine derivatives and uses thereof
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
DE102005055963A1 (en) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055957A1 (en) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP2432531B1 (en) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalation device and nebulizer
WO2011064164A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
PL2835146T3 (en) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizer
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
JP6559157B2 (en) 2014-05-07 2019-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
SG10201709354PA (en) 2014-05-07 2018-01-30 Boehringer Ingelheim Int Nebulizer, Indicator Device And Container

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DE10050995A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New benzylic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
DE10050994A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
EP1497289B1 (en) 2005-08-24
JP2005529111A (en) 2005-09-29
HRP20040944B1 (en) 2012-12-31
CA2481468A1 (en) 2003-10-23
BR0309185A (en) 2005-02-15
RS50735B (en) 2010-08-31
PL213489B1 (en) 2013-03-29
IL164291A0 (en) 2005-12-18
ATE302774T1 (en) 2005-09-15
AU2003232201B2 (en) 2009-06-11
CA2481468C (en) 2011-02-01
MXPA04009916A (en) 2005-05-03
PL372450A1 (en) 2005-07-25
HRP20040944A2 (en) 2005-04-30
CN1646527A (en) 2005-07-27
AU2003232201A1 (en) 2003-10-27
NZ536337A (en) 2007-05-31
WO2003087097A1 (en) 2003-10-23
RS89804A (en) 2006-10-27
PT1497289E (en) 2005-11-30
EP1497289A1 (en) 2005-01-19
ES2248767T3 (en) 2006-03-16
NO20044107L (en) 2004-11-04
UY27757A1 (en) 2003-11-28
IL164291A (en) 2012-04-30

Similar Documents

Publication Publication Date Title
DK1497289T3 (en) Drug containing betamimetics and a new anticholinergic
RS20050361A (en) Novel medicament for the treatment of chronic obstructive pulmonary diseases
YU35503A (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
IS8230A (en) Substitute 2-aminotetraline for use in the treatment of depression
DE60315492D1 (en) MEDICALLY USEFUL ARYLETHANOLAMINE COMPOUNDS
YU71901A (en) NOVEL MEDICAMENT COMPOSITIONS, BASED ON ANTICHOLINERGICALLY EFFECTIVE COMPOUNDS AND beta-MIMETICS
MXPA03005340A (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides.
CY1106430T1 (en) MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG
ATE479433T1 (en) NEW LONG-ACTING BETA-2 AGONISTS AND THEIR USE AS MEDICINAL PRODUCTS
UA85707C2 (en) Benzoxazines for treating respiratory tract diseases
WO2003087049A3 (en) Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent
EA200600854A1 (en) NEW TIOTROPY SALTS, METHOD OF THEIR PRODUCTION, AND ALSO CONTAINING THEIR MEDICINAL COMPOSITIONS
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
BR0307703A (en) Drug compositions based on anticholinergic agents and egfr kinase inhibitors
UY26990A1 (en) NEW DRUG COMPOSITIONS
MXPA03008406A (en) Novel medicament compositions based on anticholinergic agents and endothelin antagonists.
ECSP045357A (en) MEDICINAL CONTAINING BETAMIMETICS AND A NEW ANTI-POLERIGEN
DE502007006951D1 (en) MEDICINAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
MXPA03005585A (en) Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists.
DE50309096D1 (en) TIOTROPHIC MEDICINAL COMBINATION FOR INHALATION
MXPA04002400A (en) Salicylic acid salts, methods for the production and use thereof as medicaments.